Healthy Aging & Longevity
Tesamorelin
A stabilized GHRH analog with the most substantial clinical research base of the growth hormone secretagogues.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- 2mg vial — reconstituted injectable$230
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone. It is distinguished from other secretagogues by a comparatively developed clinical literature, particularly regarding visceral adipose tissue.
Mechanism
How it works
Tesamorelin binds pituitary GHRH receptors to stimulate endogenous growth hormone secretion, which in turn raises IGF-1. Research has focused notably on its effect on visceral rather than subcutaneous fat.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored for visceral adipose tissue reduction
- Discussed within metabolic health protocols
- Potential support for body composition
- Commonly tracked with IGF-1 and metabolic panels
Administration
Format & dosing
Once-daily subcutaneous injection, usually at night. Protocols are typically longer-running with periodic lab reassessment.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for Tesamorelin after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Baseline Labs Generally Required
Commonly reviewed at baseline
- IGF-1
- Comprehensive metabolic panel (CMP)
- Fasting glucose and A1c
- Lipid panel
- Thyroid panel (TSH, free T4)
Follow-up & monitoring
IGF-1 and glycemic markers are typically reassessed at 8 to 12 weeks, then periodically while therapy continues.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Active pituitary disease
- Uncontrolled diabetes
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded preparations are not FDA-approved products. Not appropriate with active malignancy. Glucose tolerance should be monitored in at-risk patients.
Regulatory status: Off-Label. Evidence level: Established. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Healthy Aging & Longevity
CJC-1295 / Ipamorelin
Growth hormone optimization for body composition and recovery.
Baseline Labs Generally Required
Healthy Aging & Longevity
Tesamorelin / Ipamorelin
Dual GH secretagogue stack for fat loss and body composition.
Baseline Labs Generally Required
Healthy Aging & Longevity
MOTS-C
Mitochondrial-derived peptide for metabolic health and endurance.
Recent Labs Recommended
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.